-VISIT OUR OTHER FORUMS- OB-GYN-L Ultrasound Ultrasound History Fibroid Forum Physicians-in-Training Tech Talk OBSTET-L (portuguese) OBGIN-L (spanish) Nursing

Re: discontinuation of tamoxifen From: Henry Gregor (henrygregor@yahoo.com) Wed Mar 2 10:40:29 2005 Messages sorted by: [ date ][ thread ][ subject ][ author ] Next message: Henry Gregor: "Re: OB: Upper midline incision" Previous message: Charlie Chambers: "Re: Upper midline incision" In reply to: Joanne Bulley, MD: "Re: discontinuation of tamoxifen" I've talked to several oncologists over the past year, and read a couple of pieces, and it seems to me the whole area of aromotases (kinda' reminds me of med school biochemistry and abrcadabrases, I never did get those down) is an area in evolution. Might want to speak with someone specifically in the breast CA mgt area to get some input from there. I know this question of what to do after Tamoxifen (or should one switch partway through Tamoxifen therapy) is being widely discussed. Hank "Joanne Bulley, MD" <islesannie@yahoo.com> wrote: Ah-ha! No breast Cancer! In this instance you have done what you can to reduce her risk and I think she then stays off the Tamoxifen and doesn't "need" anything else. If she has further questions - I would get her to go to a Breast Cancer Center for discussion. I think changing to Evista just for breast protection would be about the same as continuing the Tamoxifen. Same ongoing clotting risks etc -- but less uterine risk. Joanne At Tue, 1 Mar 2005, Richard Chudacoff, MD wrote: > >I started her on the Tamoxifen based on an elevated Gail Risk number. I gave >her the option of going to a breast care clinic 5 years ago and she >declined. She does not have, nor has she ever had, breast cancer. > >-- >Richard Chudacoff, MD > >-----Original Message----- >From: ob-gyn-l@obgyn.net [mailto:ob-gyn-l@obgyn.net] On Behalf Of art >fougner, md >Sent: Tuesday, March 01, 2005 8:11 AM >To: Multiple recipients of list OB-GYN-L >Subject: Re: discontinuation of tamoxifen > >Rich > >what does her oncologist suggest? > >art > >At Mon, 28 Feb 2005, Richard Chudacoff, MD wrote: >> >>I have a patient who will finish five years of tamoxifen prophylaxis for >>high risk breast cancer this August. Now what? >> >>-- >>Richard Chudacoff, MD, FACOG >> >>Women's Specialist of Houston >> >>6244 Fannin Suite 1800 >> >>Houston, TX, 77030 >> >>713-797-1144 >> >>713-425-3071 >> >>Women's Wellness Center at >> >>Chudacoff OB & GYN, PA >> >>15200 Soutwest Freeway #270 >> >>Sugar Land, TX 77478 >> >>tel: 281-277-3900 >> >>fax: 281-277-3901 >> >>Email: Richard.Chudacoff@obgyn.net >> >> rchudacoff@mylinuxisp.com >> >-- >art fougner, md > > "If you don't know where you are going, you will wind up somewhere else." >Lawrence Peter Berra > -- Joanne Bulley, MD Keene, NH, USA Yahoo! Netrospective: 100 Moments of the Web Next message: Henry Gregor: "Re: OB: Upper midline incision" Previous message: Charlie Chambers: "Re: Upper midline incision" In reply to: Joanne Bulley, MD: "Re: discontinuation of tamoxifen"

Return to

Mail a New Message to the Forum: ob-gyn-l@obgyn.net Forum Administrator: geffrey.klein@obgyn.net Report Technical Problems: webmaster@obgyn.net Last Updated: Tue Sep 2 05:02:55 2008

The American Medical Association is no longer designating CME hours for AMA Category II CME credit. However, physicians themselves may self designate learning activities as Category II CME credit hours if they feel it is of sufficient educational merit and meets the formal definitions of continuing medical education. OBGYN.net believes these interaction in this forum meets these criteria. For further information see the AMA web site.